Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Edaravone and Dexborneol Sublingual Tablets

Approval Number

国药准字H20240041

Company海南先声药业有限公司

Registration Date

December 1, 2024

Drug Information

Generic Name

依达拉奉右莰醇舌下片

Dosage Form

片剂

Strength

含依达拉奉30mg和右莰醇6mg

Drug Type

化学药品

Registration Date

December 1, 2024

Company Information

Applicant Company

Company Name海南先声药业有限公司

Company Address

江苏省南京江北新区华康路99号

Manufacturing Company

Company Name药源生物科技（启东）有限公司

Company Address

启东高新技术产业开发区江枫路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy